COSCIENS Biopharma Inc. (CSCI)

COSCIENS Biopharma Revenue

COSCIENS Biopharma had revenue of $2.34M in the quarter ending June 30, 2024, with 4.05% growth. This brings the company's revenue in the last twelve months to $4.92M, down -43.63% year-over-year. In the year 2023, COSCIENS Biopharma had annual revenue of $4.50M, down -20.25%.

• Revenue (ttm): $4.92M
• Revenue Growth: -43.63%
• P/S Ratio: n/a
• Revenue / Employee: $409,583
• Employees: 12
• Market Cap: 13.38M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2023	4.50M	-1.14M	-20.25%
Dec 31, 2022	5.64M	380.00K	7.22%
Dec 31, 2021	5.26M	1.61M	44.03%
Dec 31, 2020	3.65M	3.12M	586.47%
Dec 31, 2019	532.00K	-26.35M	-98.02%

Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.